Literature DB >> 25931164

In Silico Analysis of NF2 Gene Missense Mutations in Neurofibromatosis Type 2: From Genotype to Phenotype.

Thomas E Heineman1, D Gareth R Evans, Fabien Campagne, Samuel H Selesnick.   

Abstract

HYPOTHESIS: Computer-based (in silico) protein modeling to examine genotype-phenotype relationships for a given mutation has been applied to many genes but never to NF2.
BACKGROUND: Missense mutations in the merlin protein occur in approximately 9% of patients with neurofibromatosis type 2 (NF2). Within this subset of patients, no genotype-phenotype correlations have been established. The aim of this study was to determine if genotype correlates with phenotype in the cohort of NF2 patients with missense mutations as a first step to defining a method to predict clinical phenotype from genotype for these patients.
METHODS: We analyzed 45 patients with NF2 as a result of missense mutations drawn from the United Kingdom NF2 registry. Our analysis included 17 different NF2 mutations from NF2 patients and six single-nucleotide polymorphisms (SNP)--presumed benign because they are observed in the dbSNP National Center for Biotechnology Information database and 1000 Genomes. We analyzed the mutations using three mutation tolerance prediction approaches: Align GVGD, SIFT, and PolyPhen-2. The mutation sites were also modeled on the three-dimensional crystal structure of merlin to investigate the spatial relationship of NF2-causing mutations.
RESULTS: Two mutation tolerance predictors (SIFT and PolyPhen-2) were able to distinguish NF2-causing mutations from non-NF2-causing SNPs (p < 0.05). Mapping mutations on the molecular structure of merlin suggest that mutations resulting in greater structural conflicts within the protein are more likely to correlate with severe phenotypes.
CONCLUSION: This work is a step toward a better understanding of genotype-phenotype relationships in NF2 caused by missense mutations using a computer-based methodology.

Entities:  

Mesh:

Year:  2015        PMID: 25931164     DOI: 10.1097/MAO.0000000000000639

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  3 in total

Review 1.  Diagnostics and therapy of vestibular schwannomas - an interdisciplinary challenge.

Authors:  Steffen Rosahl; Christopher Bohr; Michael Lell; Klaus Hamm; Heinrich Iro
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2017-12-18

Review 2.  Genomics, Epigenetics, and Hearing Loss in Neurofibromatosis Type 2.

Authors:  Christine T Dinh; Eric Nisenbaum; Darius Chyou; Carly Misztal; Denise Yan; Rahul Mittal; Juan Young; Mustafa Tekin; Fred Telischi; Cristina Fernandez-Valle; Xue-Zhong Liu
Journal:  Otol Neurotol       Date:  2020-06       Impact factor: 2.619

3.  Re-evaluation of missense variant classifications in NF2.

Authors:  Katherine V Sadler; Charlie F Rowlands; Philip T Smith; Claire L Hartley; Naomi L Bowers; Nicola Y Roberts; Jade L Harris; Andrew J Wallace; D Gareth Evans; Ludwine M Messiaen; Miriam J Smith
Journal:  Hum Mutat       Date:  2022-04-02       Impact factor: 4.700

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.